Adverse Experience Reporting. The Principal Investigator shall notify Sponsor of serious adverse experiences, adverse experiences or drug reactions of any Study Subject in accordance with the requirements of the Protocol.
Appears in 3 contracts
Sources: Clinical Trial Agreement, Clinical Trial Agreement, Clinical Trial Agreement